Supersaturated Oxygen Therapy Study to Assess Utility, Cost-effectiveness
The first patient has enrolled in a study to assess the clinical utility and cost-effectiveness of Zoll TherOx SuperSaturated Oxygen (SSO2) Therapy.
Tag: Zoll TherOx SSO2 Therapy
All
Latest
All
Latest
FDA Approves Updated SSO2 Therapy for LAD-STEMI Patients
The US FDA approved Zoll Medical's second-generation TherOx SuperSaturated Oxygen (SSO2) Therapy System for patients suffering LAD-STEMI.
